Home › Compare › UGEIF vs JNJ

UGEIF vs JNJ: Dividend Comparison 2026

UGEIF yields 136.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UGEIF wins by $15.89M in total portfolio value
10 years
UGEIF
UGEIF
● Live price
136.99%
Share price
$1.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.91M
Annual income
$6,531,395.31
Full UGEIF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — UGEIF vs JNJ

📍 UGEIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUGEIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UGEIF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
UGEIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UGEIF
Annual income on $10K today (after 15% tax)
$11,643.84/yr
After 10yr DRIP, annual income (after tax)
$5,551,686.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, UGEIF beats the other by $5,550,982.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UGEIF + JNJ for your $10,000?

UGEIF: 50%JNJ: 50%
100% JNJ50/50100% UGEIF
Portfolio after 10yr
$7.97M
Annual income
$3,266,111.55/yr
Blended yield
41.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UGEIF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-1.5
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UGEIF buys
0
JNJ buys
0
No recent congressional trades found for UGEIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUGEIFJNJ
Forward yield136.99% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$15.91M$20.0K ✓
Annual income after 10y$6,531,395.31 ✓$827.78
Total dividends collected$14.62M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: UGEIF vs JNJ ($10,000, DRIP)

YearUGEIF PortfolioUGEIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$24,399$13,698.63$10,676$355.77+$13.7K → UGEIF
2$57,343$31,236.24$11,407$389.39+$45.9K → UGEIF
3$129,967$68,610.14$12,198$426.53+$117.8K → UGEIF
4$284,396$145,331.12$13,056$467.62+$271.3K → UGEIF
5$601,515$297,211.14$13,987$513.12+$587.5K → UGEIF
6$1,231,116$587,495.29$14,998$563.56+$1.22M → UGEIF
7$2,441,054$1,123,759.56$16,098$619.52+$2.42M → UGEIF
8$4,694,346$2,082,418.44$17,295$681.69+$4.68M → UGEIF
9$8,765,624$3,742,673.91$18,599$750.82+$8.75M → UGEIF
10$15,910,613$6,531,395.31$20,022$827.78+$15.89M → UGEIF

UGEIF vs JNJ: Complete Analysis 2026

UGEIF — Stock

UGE International Ltd., a solar and renewable energy solutions company, provides commercial and community solar energy solutions to commercial and industrial clients in Canada, the United States, and the Philippines. It develops, builds, owns, operates, deploys, and finances solar projects, as well as offers engineering and consulting services. The company was founded in 2008 and is headquartered in Toronto, Canada.

Full UGEIF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this UGEIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UGEIF vs SCHDUGEIF vs JEPIUGEIF vs OUGEIF vs KOUGEIF vs MAINUGEIF vs ABBVUGEIF vs MRKUGEIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.